Mercado cerrado -
Otros sitios de cotización
|
Después de cerrar 16:27:11 | |||
1,4 SEK | -96,26 % | 1,56 | +11,43 % |
29/04 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 | |
29/04 | Immunovia nombra a Lisa Ford directora del laboratorio clínico | CI |
Resumen de negocios
Número de empleados: 11
Ventas por actividad
SEK en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Non-invasive Blood Tests
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +35,66 % |
Ventas por región
SEK en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Sweden
59,1
%
| 1 | 59,2 % | 1 | 59,1 % | +35,40 % |
United States
40,9
%
| 0 | 0,0 % | 0 | 40,9 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 01/04/22 | |
Karl Stone
COO | Chief Operating Officer | 61 | 01/03/23 |
Chief Tech/Sci/R&D Officer | - | 01/02/23 | |
Linda Mellby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas C. King
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/01/17 |
Philipp Mathieu
BRD | Director/Board Member | 46 | 20/01/22 |
Tobias Bülow
IRC | Investor Relations Contact | - | 15/01/22 |
Cindy Callahan
SAM | Sales & Marketing | - | - |
Jon Hager
SAM | Sales & Marketing | - | 05/12/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 70 | 09/12/16 | |
Peter Andersen
CHM | Chairman | 67 | 01/01/20 |
Michael Löfman
BRD | Director/Board Member | - | 22/05/23 |
Martin Møller
BRD | Director/Board Member | 49 | 01/01/21 |
Eric Krafft
BRD | Director/Board Member | 49 | 01/04/22 |
Philipp Mathieu
BRD | Director/Board Member | 46 | 20/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 45 287 498 | 34 016 137 ( 75,11 %) | 0 | 75,11 % |
Información de la empresa
Sector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-13,12 % | 18,53 mil M | |
-39,81 % | 2820,18 M | |
+23,79 % | 1910,59 M | |
+1,29 % | 1650,13 M | |
+28,27 % | 1252,72 M | |
-14,61 % | 988 M | |
-20,31 % | 910 M | |
+2,50 % | 786 M | |
-24,73 % | 634 M |
- Bolsa de valores
- Acciones
- Acción IMMNOV
- Acción 0G8X
- Empresa Immunovia AB